Associated Papers
The reovirus variant RP116 is oncolytic in immunocompetent models and generates reduced neutralizing antibodies to Type 3 Dearing.
Song KH et al.
Molecular Therapy. Oncology, 2024
39354956 (PubMed )
Supplement: mmc2.pdf
The Interplay Between Apolipoprotein E4 and the Autophagic-Endocytic-Lysosomal Axis.
Schmukler E et al.
Molecular Neurobiology, 2018
Glioblastoma-secreted soluble CD44 activates tau pathology in the brain.
Lim S et al.
Experimental & Molecular Medicine, 2018
mTORC2 Regulates Amino Acid Metabolism in Cancer by Phosphorylation of the Cystine-Glutamate Antiporter xCT.
Gu Y et al.
Molecular Cell, 2017
Regulatory factor X1 is a new tumor suppressive transcription factor that acts via direct downregulation of CD44 in glioblastoma.
Feng C et al.
Neuro-oncology, 2014
Molecular alterations in glioblastoma: potential targets for immunotherapy.
Haque A et al.
Progress in Molecular Biology and Translational Science, 2011
Sequence requirements for regulated RNA splicing of the human fibroblast growth factor receptor-1 alpha exon.
Cote GJ et al.
The Journal of Biological Chemistry, 1997
Select a paper to view details